These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17109963)

  • 1. Candidate inhibitors of porcine complement.
    Thorgersen EB; Ghebremariam YT; Thurman JM; Fung M; Nielsen EW; Holers VM; Kotwal GJ; Mollnes TE
    Mol Immunol; 2007 Mar; 44(8):1827-34. PubMed ID: 17109963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
    Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
    Salvesen B; Nielsen EW; Harboe M; Saugstad OD; Mollnes TE
    Mol Immunol; 2009 Feb; 46(4):688-94. PubMed ID: 18950866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
    Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation.
    Saethre M; Lea T; Borgen MS; Fiane AE; Michaelsen TE; Thorsby E; Haraldsen G; Mollnes TE
    Xenotransplantation; 2006 May; 13(3):215-23. PubMed ID: 16756564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroluminescent TCC, C3dg and fB/Bb epitope assays for profiling complement cascade activation in vitro using an activated complement serum calibration standard.
    van Vuuren BJ; Bergseth G; Mollnes TE; Shaw AM
    J Immunol Methods; 2014 Jan; 402(1-2):50-6. PubMed ID: 24287422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyanobacterial LPS antagonist (CyP)-a novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig.
    Thorgersen EB; Macagno A; Rossetti C; Mollnes TE
    Mol Immunol; 2008 Aug; 45(13):3553-7. PubMed ID: 18571239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification.
    Harboe M; Garred P; Karlstrøm E; Lindstad JK; Stahl GL; Mollnes TE
    Mol Immunol; 2009 Dec; 47(2-3):373-80. PubMed ID: 19800125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathway-specific complement activity in pigs evaluated with a human functional complement assay.
    Salvesen B; Mollnes TE
    Mol Immunol; 2009 May; 46(8-9):1620-5. PubMed ID: 19328551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome.
    Prüfer F; Scheiring J; Sautter S; Jensen DB; Treichl R; Würzner R; Zimmerhackl LB
    Semin Thromb Hemost; 2006 Mar; 32(2):121-7. PubMed ID: 16575687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).
    Jansen JH; Høgåsen K; Mollnes TE
    Am J Pathol; 1993 Nov; 143(5):1356-65. PubMed ID: 8238252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.
    Thurman JM; Kraus DM; Girardi G; Hourcade D; Kang HJ; Royer PA; Mitchell LM; Giclas PC; Salmon J; Gilkeson G; Holers VM
    Mol Immunol; 2005 Jan; 42(1):87-97. PubMed ID: 15488947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APT070 inhibits complement activation during in vitro cardiopulmonary bypass.
    De Silva RJ; Vuylsteke A; Fritchley SJ; Trull AK; Dunning JJ; Wallwork J
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):72-6. PubMed ID: 16723247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation.
    Beinrohr L; Dobó J; Závodszky P; Gál P
    Trends Mol Med; 2008 Dec; 14(12):511-21. PubMed ID: 18977695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD59 efficiently protects human NT2-N neurons against complement-mediated damage.
    Pedersen ED; Aass HC; Rootwelt T; Fung M; Lambris JD; Mollnes TE
    Scand J Immunol; 2007; 66(2-3):345-51. PubMed ID: 17635812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships for substrate-based inhibitors of human complement factor B.
    Ruiz-Gómez G; Lim J; Halili MA; Le GT; Madala PK; Abbenante G; Fairlie DP
    J Med Chem; 2009 Oct; 52(19):6042-52. PubMed ID: 19743866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models.
    Laumonier T; Walpen AJ; Matozan KM; Korchagina EY; Bovin NV; Haeberli A; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 May; 11(3):262-8. PubMed ID: 15099206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement inhibition by FUT-175 and K76-COOH in a pig-to-human lung xenotransplant model.
    Blum MG; Collins BJ; Chang AC; Zhang JP; Knaus SA; Pierson RN
    Xenotransplantation; 1998 Feb; 5(1):35-43. PubMed ID: 9507731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation in experimental human malaria infection.
    Roestenberg M; McCall M; Mollnes TE; van Deuren M; Sprong T; Klasen I; Hermsen CC; Sauerwein RW; van der Ven A
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):643-9. PubMed ID: 17481680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the dose dependence of endotoxin-induced in vitro activation of the complement system.
    Roeise O; Garred P; Mollnes TE; Aasen AO
    Eur Surg Res; 1989; 21(1):34-41. PubMed ID: 2714308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.